|

Tazemetostat Pill Clinical Trials

2 actively recruiting trials across 1 location

Also known as: Tazverik

Pipeline

Phase 1: 1Phase 2: 1

Top Sponsors

  • Weill Medical College of Cornell University2

Indications

  • Follicular Lymphoma2
  • Cancer2
  • B Cell Lymphoma1
  • Mantle Cell Lymphoma1
  • Diffuse Large B-Cell Lymphoma1

New York, New York2 trials

A Feasibility Trial of Tazemetostat Plus CAR T Cell Therapy in B-cell Lymphomas

Weill Cornell Medicine/NewYork-Presbyterian Hospital

Phase 1
Tazemetostat and Mosunetuzumab in Untreated Follicular Lymphoma

Weill Cornell Medicine/NewYork-Presbyterian Hospital

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.